Proteocyte AI is a Canadian med-tech company based in Toronto, dedicated to developing lab tests to predict the risk of developing cancer. Their flagship product, Straticyte, is a digitally delivered oral cancer predictor. With a focus on reducing cancer incidence worldwide, Proteocyte AI aims to provide better testing, better guidance, and better outcomes for patients.

By designing tests that accurately predict an individual's risk of developing cancer, Proteocyte AI empowers clinicians and patients to make informed decisions about their health. The company has assembled a team of highly experienced professionals, including renowned experts in the fields of otolaryngology, pathology, and oral and maxillofacial surgery. Through cutting-edge research and innovative technology, Proteocyte AI is at the forefront of advancing cancer risk assessment, with the ultimate goal of saving lives